Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go:
14
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
An innovative and flourishing brewery, with music as its main source of inspiration. Signature Brew has won multiple awards for their beers, including the SIBA for Brewery Business of the Year 2018. The company is passionate abut serving brews alongside bands; their collaborations include Foo Fighters, Frank Turner, Mastodon and alt-J.
Signature Brew's core beers are enjoyed nationwide, such as Studio Pilsner and Roadie. Their products are sold in bars, pubs and supermarkets, as well as at venues and festivals. Over the past 3 years, the company has seen YoY growth of 78%, with revenues of £1.13m in the last 12 months.
Signature Brew is currently producing over 1m pints per year and is now seeking investment to increase capacity. The company intends to move its services to a nearly site in East London and develop a new brew house. This will result in capacity increasing by three-fold. In addition, Signature Brew intends to open two more taprooms to host events and showcase their beers.
days to go:
Expired
investment:
£567,030
Soupfix is a gourmet soup company that are planning to bring fresh and healthy soups to the city. Soupfix are currently using pop up locations in popular areas to bring a new lunchtime choice for city workers.
days to go:
Expired
investment:
£41,010
Specilaing in making a wide variety of award-winning pies and pastry products for the public. Eat Square's 2017 funding round has resulted in their turnover more than doubling in 2018. This growth has led to Eat Square expanding their business and begin to sell franchises to market their goods. Production and capacity have also increased and products that are vegan and gluten-free are being produced. This funding round will see the business sell up to 14 franchises by the end of 2019 to buy their pies.
days to go:
Expired
investment:
£34,019
A brewery with gold awards from SIBA and CAMRA, as well as being voted No. 1 in Hertfordshire by Rate Beer, Mad Squirrel is seeking investment to expand even further with the aim of opening two more taprooms before the end of 2018 and plans for three more by 2020. Mad Squirrel has grown more than 180% in three years with MAT revenues up by more than 45%.
days to go:
Expired
investment:
£303,850
Licklist is currently one of the UK's largest directories for nightlife and music festivals. Using Licklist, 18-30 year olds can plan their perfect night out, allowing them to discover events, offers and venues. For nightclubs and bars, Licklist provide them with tools that help them get more people into their venue.
days to go:
Expired
investment:
£103,288
